PI3K signalling is a main driver of IGF-1-induced aerobic glycolysis in mouse mammary tumour cells (Landis and Shaw, 2014), and mediates IGF-1-stimulated glucose uptake in mouse adipocytes (Assefa et al., 2017). Here, IGF1 is linked to breast cancer.